Magnetic resonance imaging as an adjunct diagnostic tool in computed tomography defined Bosniak IIF-III renal cysts: a multicenter study

. 2018 Jun ; 36 (6) : 905-911. [epub] 20180130

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/pmid29383479
Odkazy

PubMed 29383479
DOI 10.1007/s00345-018-2176-z
PII: 10.1007/s00345-018-2176-z
Knihovny.cz E-zdroje

INTRODUCTION: CT imaging is the standard examination for renal cystic lesions and defines the Bosniak category, which dictates further management. Given that Bosniak II/IIF/III renal cystic lesions can potentially harbor renal cell carcinoma (RCC), additional diagnostic modalities may be required in management decision making. AIM: To determine the value of additional magnetic resonance imaging in CT-defined Bosniak IIF-III renal cystic lesions. MATERIALS AND METHODS: This a multicenter retrospective study of 46 consecutive patients, diagnosed with cystic renal lesions between 2009 and 2016. The inclusion criteria were: (1) cystic renal lesion classified as Bosniak IIF-III on CT, (2) a subsequent MRI examination, and (3) documented outcome via surgery for cystic renal mass or follow-up. RESULTS: 46 patients (35 males, 11 females) were included. The mean size of the cystic lesion was 3.92 cm (0.7-10 cm). According to the CT findings, Bosniak IIF and III were found in 12 (26.1%) and 34 (73.9%) cases. Reclassification of Bosniak category was done after MRI examination in 31 cases (67.4%). An upgrade rate of 58.7% (27 cases) to a higher category was made, while the downgrade rate to a lower category was achieved in 4 cases (8.7%). As a result, significant therapeutic management change was made in 12/31 patients (38.7%), of whom 8 underwent subsequent surgery. CONCLUSION: MRI study may reduce the use of Bosniak IIF category (in comparison with CT), which has a direct impact on therapeutic management (surgery vs. surveillance) in a significant proportion of patients.

Zobrazit více v PubMed

Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E8-E14 PubMed

Urology. 2005 Sep;66(3):484-8 PubMed

Radiology. 2007 Apr;243(1):158-65 PubMed

Radiology. 1986 Jan;158(1):1-10 PubMed

Biomed Res Int. 2015 ;2015 :172165 PubMed

Radiographics. 2004 Oct;24 Suppl 1:S101-15 PubMed

Radiology. 2003 Jan;226(1):47-52 PubMed

Scand J Urol Nephrol. 2011 Sep;45(4):239-44 PubMed

Int Urol Nephrol. 2005;37(4):743-50 PubMed

AJR Am J Roentgenol. 2003 Sep;181(3):627-33 PubMed

Eur Radiol. 2007 Nov;17 (11):2780-93 PubMed

Curr Opin Urol. 2010 Sep;20(5):349-54 PubMed

AJR Am J Roentgenol. 2000 Aug;175(2):339-42 PubMed

Curr Urol Rep. 2012 Feb;13(1):93-8 PubMed

Urol Clin North Am. 1993 May;20(2):217-30 PubMed

AJR Am J Roentgenol. 1997 Sep;169(3):819-21 PubMed

Eur Urol. 2006 May;49(5):798-805 PubMed

Arab J Urol. 2017 Mar 30;15(2):115-122 PubMed

Eur Urol. 2016 Jul;70(1):93-105 PubMed

Abdom Radiol (NY). 2016 Oct;41(10 ):2011-9 PubMed

Radiology. 2012 Jan;262(1):152-60 PubMed

World J Urol. 2015 Mar;33(3):295-300 PubMed

Radiology. 1999 Nov;213(2):468-72 PubMed

Radiology. 2004 May;231(2):365-71 PubMed

J Urol. 1997 May;157(5):1852-3 PubMed

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

A Comprehensive Commentary on the Multilocular Cystic Renal Neoplasm of Low Malignant Potential: A Urologist's Perspective

. 2022 Feb 06 ; 14 (3) : . [epub] 20220206

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...